P. Dulíček

发表

Fibrin Clot Architecture in Acute Ischemic Stroke Treated With Mechanical Thrombectomy With Stent-Retrievers　- Cohort Study.

O. Vysata, M. Valis, I. Šteiner, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide

M. Penka, P. Ovesná, J. Schwarz, 2020, Journal of Thrombosis and Thrombolysis.

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

C. Schlimp, J. Mutzenbach, M. Voško, 2017, Journal of Thrombosis and Thrombolysis.

Risk and Prognostic Factors in Cerebral Venous Thrombosis

F. Gabalec, F. Vrbacky, P. Sadílek, 2017 .

Thrombophilia Work-up in Females with Venous Thromboembolism in Association with Oral Contraceptive Use: Results, Strategy and Clinical Application of Testing

M. Beranek, P. Sadílek, P. Dulíček, 2017 .

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.

K. Krejcy, C. Klade, R. Kralovics, 2020, The Lancet. Haematology.

Thrombosis in thrombocythemic Ph‐ myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

J. Kissová, M. Penka, L. Křen, 2016, European journal of haematology.

Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

P. Žák, M. Beranek, P. Sadílek, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Novel Evidence-Based Diagnosis, Classification and Management of Lower Extremity Deep Vein Thrombosis (DVT), Prevention of DVT Recurrence and the Post-Thrombotic Syndrome: Personal Experiences and Critical Appraisal of the Literature 1998-2018

K. Roztočil, B. Cosmi, L. Gašpar, 2018 .

Complete Compression Ultrsonography, Clinical Score, Underlying Risk Factors and D-Dimer Testing for Objective Evidence Based Diagnosis and Exclusion of Deep Vein Thrombosis and Alternative Diagnoses in the Primary Care and Hospital Setting

R. Strijkers, J. Michiels, P. Dulíček, 2015 .

Complete Compression Ultrsonography, Clinical Score, Underlying Risk

R. Strijkers, J. Michiels, P. Dulíček, 2015 .

The Impact of Rheohaemapheresis on the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) in Age-Related Macular Degeneration

H. Langrová, M. Bláha, J. Studnicka, 2020 .

Heparin-induced thrombocytopenia treated with fondaparinux: single centre experience.

P. Sadílek, P. Dulíček, M. Košťál, 2019, International angiology : a journal of the International Union of Angiology.

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

K. Krejcy, C. Klade, R. Kralovics, 2020, HemaSphere.

Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

F. Dentali, G. Lessiani, L. Mazzolai, 2017, Research and practice in thrombosis and haemostasis.

Rivaroxaban - 4 year experience in the treatment of deep vein thrombosis

P. Dulíček, 2016 .

Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A.

D. Habart, M. Matýšková, A. Buliková, 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Diagnosis and treatment of DVT and prevention of DVT recurrence and the PTS: bridging the gap between DVT and PTS in the primary care setting or outpatient ward

G. Palareti, P. Poredos, H. Neumann, 2017 .

Risk of Thrombosis in Patients Homozygous and Heterozygous for Factor V Leiden in the East Bohemian Region

J. Malý, P. Dulíček, M. Šafářová, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity.

M. Svoboda, P. Dulíček, V. Koblizek, 2019, Journal of the American Medical Directors Association.

Failure of therapy or resistance to antiplatelet drugs

H. Ševčíková, J. Vojáček, R. Pudil, 2009 .

Oral Contraceptives and Venous Thromboembolism

S. Shapiro, J. Verhaeghe, D. Seidman, 2010, Journal of Family Planning and Reproductive Health Care.

Oral Contraceptives and Venous Thromboembolism-Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

Workshop Participants/ Consensus Opinion Contributors

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

Germany in December 2009 an International Workshop held in Berlin , Thromboembolism : Consensus Opinion from Oral Contraceptives and Venous

S. Shapiro, J. Verhaeghe, D. Seidman, 2010 .

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

K. Krejcy, C. Klade, R. Kralovics, 2022, Leukemia.

Treatment of polycythemia vera.

P. Dulíček, 2018, Vnitrni lekarstvi.

Is Factor V Leiden Associated with an Increased Risk for Fetal Loss

L. Chrobák, M. Pecka, P. Stránský, 2001 .

Is factor V Leiden a risk factor for fetal loss?

L. Chrobák, M. Pecka, P. Stránský, 1999, Acta medica.

The Frequency of Venous Thromboembolism in Women with FV Leiden in Association with Pregnancy and Puerperium

M. Beranek, J. Malý, M. Pecka, 2006 .

Is Travelling a Risk Factor for Venous Thrombosis in Individuals with Factor V Leiden in Heterozygous Form

M. Beranek, J. Malý, P. Dulíček, 2005 .

Severe Haemophilia A Patient with Factor V Leiden Homozygosity Associated with Portal Vein Thrombosis and Myocardial Infarction

L. Chrobák, V. Řeháček, P. Dulíček, 1999 .

Prevalence of APC-Resistance in the East Bohemian Region

L. Chrobák, V. Řeháček, P. Dulíček, 1998 .

Venous Thromboembolism in Young Female While on Oral Contraceptives: High Frequency of Inherited Thrombophilia and Analysis of Thrombotic Events in 400 Czech Women

M. Beranek, R. Malý, E. Čermáková, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients.

V. Palička, M. Beranek, P. Dulíček, 2022, Physiological research.

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,

M. Penka, P. Ovesná, Y. Brychtova, 2011 .

The Purple Toe Syndrome in Female With Factor V Leiden Mutation Successfully Treated With Enoxaparin

J. Bartová, M. Beranek, J. Malý, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.

G. Palareti, V. Štvrtinová, H. Neumann, 2014, International angiology : a journal of the International Union of Angiology.

[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].

D. Pospíšilová, J. Kissová, M. Penka, 2011, Vnitrni lekarstvi.

Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort

P. Salaj, P. Dulíček, Věra Geierová, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients

C. Klade, R. Kralovics, H. Gisslinger, 2016 .

Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT

K. Krejcy, C. Klade, R. Kralovics, 2018, Blood.

Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in Polycythemia Vera: Two-Year Results from the First Prospective Randomized Controlled Trial

K. Krejcy, C. Klade, R. Kralovics, 2017 .